Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV‐1 Infection

Biotechnology Journal(2020)10.1002/biot.202000023Source: DataRank Database

Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV‐1 Infection is a research paper published in Biotechnology Journal (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.27)OA: hybridTopics (39)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Alexandre Juillerat ORCID,Yik Lim Kok,Markus Hildenbeutel,Manuel Rhiel ORCID,Geoffroy Andrieux ORCID

Live enrichment

PubMed:33103367 OpenAlex:https://openalex.org/W3093796077

German Federal Ministry of Education and Research

Grant: BMBF-01EO1303

Research cooperation with Cellectis

Grant: ZVS20170614

FWCI

1.27

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/biot.202000023

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/biot.202000023

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/biot.202000023

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/biot.202000023

publisherhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/pdf/10.1002/biot.202000023

Fields of Study

CRISPR and Genetic EngineeringHIV Research and TreatmentMosquito-borne diseases and controlDisease ResistanceHIV InfectionsHIV-1HumansReceptors, CCR5Transcription Activator-Like Effector NucleasesTranscription Activator-Like Effectors

MeSH Terms

Transcription Activator-Like Effector NucleasesTranscription Activator-Like EffectorsHumansHIV-1HIV InfectionsReceptors, CCR5Disease Resistance

Keywords

Transcription activator-like effector nucleaseGenome editingBiologyEffectorPrimary immunodeficiencyCXCR4VirologyTransplantationChemokine receptorStem cellCRISPRImmunologyGeneGeneticsChemokineReceptorMedicineImmune systemHuman immunodeficiency virus type 1Hiv CureCcr5 KnockoutC-c Chemokine Receptor Type 5 Editing

Sustainable Development Goals

SDG 0: Good health and well-being